Candidates for 2016 ERP of the Year
ERP PROFILE SUMMARIES
PROFILE OF AOAC EXPERT REVIEW PANEL FOR SPDS – CHONDROITIN, PDE5 INHIBITORS, & ANTHOCYANIN METHODS ERP Name AOAC Expert Review Panel for Dietary Supplements – Chondroitin, PDE5 Inhibitors, and Anthocyanin Methods Chair(s) Brian Schaneberg (Starbucks)
ERP Formed:
2015 Number of
Number of Methods Recommended
1 as First Action status
None Yet
Methods Adopted
Scope: Roster
Review and adopt methods resulting from sole source submission of methods for dietary supplements
Anthocyanins: 1. Brian Schaneberg, Starbucks (Chair); 2. Phil Koerner, Phenomenex; 3. Jungmin Lee, USDA; 4. Melissa Phillips, NIST; 5. Martha Jennens, Covance; 6. Tom Phillips, State of MD; 7. Aniko Solyom, GAAS Analytics; 8. John Spzylka, Mérieux NutriSciences; 9. Darryl Sullivan, Covance 10. Nour Eddine ES‐SAFI, Mohammed V University; 11. Liton Roy, Sancilio and Company; 12. Jerry Zweigenbaum, Agilent
Chondroitin: 1. Brian Schaneberg, Starbucks (Chair) 2. Jana Hildreth, Synutra Pure 3. Martha Jennens, Covance 4. Phillip Koerner,Phenomenex; 5. Tom Phillips, State of MD; 6. Curtis Phinney, Consultant; 7. Kelly Reins, Consultant; 8. John Spzylka, Merieux NutriSciences; Aniko Solyom, GAAS Corporation; 9. Darryl Sullivan, Covance 10. Liton Roy, Sancillo and Company; 11. Nour Edine ES‐SAFI, Mohammad V University Rabat
PDE5 Inhibitors: 1. Brian Schaneberg, Starbucks (Chair); 2. Phil Koerner, Phenomenex; 3. Katerina Mastovska, Covance; 4. Tom Phillips, State of MD; 5. Fenhong Song, FDA; 6. John Spzylka, Mérieux NutriSciences; 7. Darryl Sullivan, Covance. 8. Teresa Cain, FDA; 9. Liton Roy, Sancilio; 10. Jerry Zweigenbaum, Agilent.
Technical Documents created/used
SMPRs for Chondroitin, PDE5 Inhibitors, and Anthocyanins OMA Appendix K
Methods Adopted First Action and Final Action status
AOAC 2015.11 – Chondroitin AOAC 2015.12 ‐ PDE5 inhibitors
Final Action Methods Recommended Additional Input Awards/Recognitions
54
Made with FlippingBook